Talkspace [TALK] vs Teladoc Health [TDOC] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Talkspace Inc. wins in 9 metrics, Teladoc Health Inc. wins in 8 metrics, with 1 ties. Talkspace Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Talkspace Inc. | Teladoc Health Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 129.63 | N/A | N/A |
| Price-to-Book Ratio | 7.39 | 0.74 | Teladoc Health Inc. |
| Debt-to-Equity Ratio | 0.00 | 75.06 | Tie |
| PEG Ratio | 0.65 | -6.16 | Talkspace Inc. |
| EV/EBITDA | 128.51 | 38.86 | Teladoc Health Inc. |
| Profit Margin (TTM) | 3.41% | -7.92% | Talkspace Inc. |
| Operating Margin (TTM) | 6.08% | -4.20% | Talkspace Inc. |
| EBITDA Margin (TTM) | 6.08% | N/A | N/A |
| Return on Equity | 6.65% | -13.93% | Talkspace Inc. |
| Return on Assets (TTM) | 1.44% | -3.20% | Talkspace Inc. |
| Free Cash Flow (TTM) | $-2.11M | $137.33M | Teladoc Health Inc. |
| 1-Year Return | 82.81% | 7.00% | Talkspace Inc. |
| Price-to-Sales Ratio (TTM) | 3.79 | 0.41 | Teladoc Health Inc. |
| Enterprise Value | $774.54M | $1.28B | Teladoc Health Inc. |
| EV/Revenue Ratio | 3.38 | 0.51 | Teladoc Health Inc. |
| Gross Profit Margin (TTM) | 42.74% | 69.32% | Teladoc Health Inc. |
| Revenue per Share (TTM) | $1 | $14 | Teladoc Health Inc. |
| Earnings per Share (Diluted) | $0.04 | $-34.20 | Talkspace Inc. |
| Beta (Stock Volatility) | 1.14 | 2.08 | Talkspace Inc. |
| Short % of Float | 4.62% | 16.55% | Talkspace Inc. |
Talkspace Inc. vs Teladoc Health Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Talkspace Inc. | -0.19% | -0.19% | 0.00% | 1.17% | 48.15% | 48.15% |
| Teladoc Health Inc. | 1.63% | 5.37% | 17.30% | 38.40% | 1.63% | 5.82% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Talkspace Inc. | 82.81% | 316.80% | -36.00% | -46.84% | -46.84% | -46.84% |
| Teladoc Health Inc. | 7.00% | -70.52% | -95.30% | -42.92% | -73.79% | -73.79% |
Performance & Financial Health Analysis: Talkspace Inc. vs Teladoc Health Inc.
| Metric | TALK | TDOC |
|---|---|---|
| Market Information | ||
| Market Cap | $866.04M | $1.04B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,185,667 | 4,716,750 |
| 90 Day Avg. Volume | 4,410,209 | 4,439,277 |
| Last Close | $5.20 | $7.46 |
| 52 Week Range | $2.22 - $5.23 | $4.40 - $9.77 |
| % from 52W High | -0.57% | -23.64% |
| All-Time High | $12.45 (Feb 08, 2021) | $308.00 (Feb 15, 2021) |
| % from All-Time High | -58.23% | -97.58% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.29% | 0.00% |
| Quarterly Earnings Growth | 2.93% | 0.00% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | -0.08% |
| Operating Margin (TTM) | 0.06% | -0.04% |
| Return on Equity (TTM) | 0.07% | -0.14% |
| Debt to Equity (MRQ) | 0.00 | 75.06 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.70 | $7.77 |
| Cash per Share (MRQ) | $0.55 | $4.38 |
| Operating Cash Flow (TTM) | $8.53M | $294.36M |
| Levered Free Cash Flow (TTM) | $-5,082,000 | $226.14M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Talkspace Inc. vs Teladoc Health Inc.
| Metric | TALK (Apr 24, 2026) | TDOC (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 129.63 | N/A |
| Forward P/E | 23.57 | -6.16 |
| PEG Ratio | 0.65 | -6.16 |
| Price to Sales (TTM) | 3.79 | 0.41 |
| Price to Book (MRQ) | 7.39 | 0.74 |
| Market Capitalization | ||
| Market Capitalization | $866.04M | $1.04B |
| Enterprise Value | $774.54M | $1.28B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.38 | 0.51 |
| Enterprise to EBITDA | 128.51 | 38.86 |
| Risk & Other Metrics | ||
| Beta | 1.14 | 2.08 |
| Book Value per Share (MRQ) | $0.70 | $7.77 |
Financial Statements Comparison: Talkspace Inc. vs Teladoc Health Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | TALK (2025) | TDOC (2025) |
|---|---|---|
| Revenue/Sales | 228.87M | 2.53B |
| Cost of Goods Sold | 130.52M | 771.59M |
| COGS % of Revenue | 57.0% | 30.5% |
| Gross Profit | 98.35M | 1.76B |
| Gross Margin | 43.0% | 69.5% |
| Research & Development | 9.54M | 277.92M |
| Operating Income (EBIT) | 3.15M | -163.40M |
| Operating Margin | 1.4% | -6.5% |
| EBITDA | 6.03M | 260.18M |
| EBITDA Margin | 2.6% | 10.3% |
| Pre-Tax Income | 8.37M | -235.53M |
| Pre-Tax Income % of Revenue | 3.7% | -9.3% |
| Income Tax | 574,000 | -35.21M |
| Income Tax % of Revenue | 0.3% | -1.4% |
| Net Income (Profit) | 7.79M | -200.32M |
| Profit Margin | 3.4% | -7.9% |
Balance Sheet & Liquidity Metrics
| Metric | TALK (2025) | TDOC (2025) |
|---|---|---|
| Cash & Equivalents | 37.35M | 781.08M |
| Total Current Assets | 111.06M | 1.12B |
| Total Current Assets % of Revenue | 48.5% | 44.2% |
| Total Current Liabilities | 17.40M | 404.74M |
| Total Current Liabilities % of Revenue | 7.6% | 16.0% |
| Long-Term Debt | N/A | 1.03B |
| Long-Term Debt % of Revenue | 0.0% | 40.7% |
| Total Shareholders Equity | 117.02M | 1.39B |
| Retained Earnings | -261.44M | -16.43B |
| Retained Earnings % of Revenue | -114.2% | -649.4% |
| Property, Plant & Equipment | 144,000 | 42.03M |
Cash Flow Statement Comparison
| Metric | TALK (2025) | TDOC (2025) |
|---|---|---|
| Operating Cash Flow | 12.53M | 225.59M |
| Operating Cash Flow % of Revenue | 5.5% | 8.9% |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | -2.11M | 137.33M |
| FCF Margin | -0.9% | 5.4% |
| Debt Repayment | N/A | -550.63M |
| Common Stock Repurchase | -17.20M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TALK | TDOC |
|---|---|---|
| Shares Short | 4.91M | 29.71M |
| Short Ratio | 0.59 | 6.89 |
| Short % of Float | 4.62% | 16.55% |
| Shares Outstanding | 166.72M | 178.32M |
| Float Shares | 128.23M | 176.23M |
| % Held by Insiders | 5.21% | 0.65% |
| % Held by Institutions | 69.61% | 75.86% |
| % Held by Public | 25.18% | 23.49% |
Dividend Analysis & Yield Comparison: Talkspace Inc. vs Teladoc Health Inc.
| Metric | TALK | TDOC |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |